Clinical Trials Browser

OTHER × Carcinoma, Non-Small-Cell Lung × icotinib × Clear all

NCT05263947 2026-02-24

Bevacizumab Combined With Double Doses of Icotinib in Advanced NSCLC Patients With EGFR L858R Mutation

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT02264210 2024-09-25

CORIN

Phase 2 Completed

128 enrolled 9 charts

Adenocarcinoma of Lung, Bronchial Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05514314 2022-08-24

A Multicenter Prospective Study to Assess the Effects of Adjuvant Icotinib in EGFRm Stage I NSCLC With High-risk of Disease Recurrence After Complete Resection

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT05132985 2021-12-10

Neoadjuvant Icotinib With Chemotherapy for Epidermal Growth Factor Receptor(EGFR)-Mutated Resectable Lung Adenocarcinoma

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT05104788 2021-11-03

NeoIpower

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT03736837 2021-03-15

ALTER-L004

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT04797806 2021-03-15

SAINT

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung

NCT03983811 2019-06-12

Adjuvant Chemotherapy With or Without Intercalated Icotinib

Phase NA Unknown

Carcinoma, Non-Small-Cell Lung

NCT03123484 2017-04-21

β-elemene Combine With EGFR-TKI for Advanced EGFR-TKI-resistant NSCLC

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT01724801 2017-03-01

BRAIN

Phase 3 Completed

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT02883543 2016-08-30

First-line Icotinib With Concurrent Radiotherapy for NSCLC With EGFR Mutation

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung

NCT02738983 2016-04-14

RT Plus EGFR-TKI for Wild-type NSCLC

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT02031601 2016-03-29

TCL-1

Phase 4 Unknown

Carcinoma, Non-Small-Cell Lung

NCT02430974 2015-04-30

Chemotherapy of NSCLC With or Without Icotinib

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT02407366 2015-04-02

Icotinib With Concurrent Radiotherapy vs. Chemoradiotherapy in Non-small Cell Lung Cancer

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT02191059 2014-07-31

Phase II Clinical Study of Intermittent High Dose of Icotinib in Combination With Docetaxel to Treat Lung Cancer

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT01514877 2014-07-23

Icotinib Combined With Whole Brain Radiotherapy in Treating Multiple Brain Metastases From Non-Small Cell Lung Cancer

Phase 2 Completed

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

NCT01688713 2012-09-20

Phase II Trial of Double Dose of Icotinib in Treating Brain Metastases From Non-small Cell Lung Cancer

Phase 2 Unknown

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung